Abstract
Improved quality of life in immunocompromised patients opens travel opportunities, but administering the yellow fever (YF) vaccine is often contraindicated. We advocate re-evaluating this position for immunocompromised patients who travel frequently or who are migrating to regions in which YF is endemic.
MeSH terms
-
Adult
-
Contraindications, Drug
-
Enzyme Inhibitors / administration & dosage
-
Enzyme Inhibitors / adverse effects
-
Female
-
Humans
-
Immunocompromised Host / immunology*
-
Immunosuppressive Agents / administration & dosage
-
Immunosuppressive Agents / adverse effects
-
Male
-
Mycophenolic Acid / administration & dosage
-
Mycophenolic Acid / adverse effects
-
Risk Assessment
-
Tacrolimus / administration & dosage
-
Travel
-
Vaccination / adverse effects
-
Yellow Fever Vaccine / administration & dosage
-
Yellow Fever Vaccine / adverse effects
-
Yellow Fever Vaccine / immunology*
Substances
-
Enzyme Inhibitors
-
Immunosuppressive Agents
-
Yellow Fever Vaccine
-
Mycophenolic Acid
-
Tacrolimus